By Lisa Ryan ( April 24, 2014, 5:37 PM EDT) -- Actavis PLC said Thursday it has reached an agreement with Pfizer Inc. to end all outstanding patent litigation over the arthritis drug Celebrex, paving the way for the Ireland-based pharmaceutical giant to begin marketing its generic version of the drug in December....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.